IP38-16: First-in-humanstudy of Prostate-Specific Membrane Antigen(PSMA)-targeted chimeric antigen receptor engineered natural killer cells(CAR-NK) for Metastatic Castration Resistant Prostate Cancer(mCRPC)

Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Speakers

KP
Kehao Pan

Log in

See all the content and easy-to-use features by logging in or registering!